Search

Search Constraints

You searched for: Author/Creator Minden, Mark D.

Search Results

2. A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia. (13th October 2016)

3. A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML). (September 2016)

4. A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML). (September 2016)

5. A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia. Issue 10 (3rd October 2015)

6. A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis. (10th October 2014)

8. AML refractory to primary induction with Ida-FLAG has a poor clinical outcome. (May 2018)